Qualcomm, Inc. (QCOM) Estimates Lowered On Omnitracs Sale

Qualcomm, Inc. (QCOM) Estimates Lowered On Omnitracs Sale

Analysts Simona Jankowski, Doug Clark and Balaji Krishnamurthy at Goldman Sachs Group Inc (NYSE:GS) rate Qualcomm as a Buy.

Consistent with guidance, QUALCOMM, Inc. (NASDAQ:QCOM) completed the sale of Omnitracs, a subsidiary providing fleet management and logistics solutions, to Vista Equity Partners for $800M in cash. As previously guided, Qualcomm expects the divestiture will contribute $0.22-0.25 in EPS in 1QFY14 (Dec), which the company will include in both GAAP and non-GAAP EPS, which would imply an updated FY14 non-GAAP EPS guidance range of $5.17-5.40.

Crypto Hedge Fund Three Arrows Blows Up, Others Could Follow

CryptoA few years ago, crypto hedge funds were all the rage. As cryptocurrencies rose in value, hundreds of hedge funds specializing in digital assets launched to try and capitalize on investor demand. Some of these funds recorded double-digit gains in 2020 and 2021 as cryptocurrencies surged in value. However, this year, cryptocurrencies have been under Read More

Also see: Qualcomm The Target Of Chinese Anti-Monopoly Probe

Qualcomm’s Omnitracs sales

QUALCOMM, Inc. (NASDAQ:QCOM)’s current FY14 revenue guidance $26.0-27.5 billion (5-11% growth) already assumed only a partial quarter of Omnitracs revenue. The company estimates the sale of Omnitracs equates to about a 1 percentage point drag on full year revenue growth. Firm’s prior estimates did not include the sale, so analysts are lowering their FY14 (Sep) revenue estimate to $27.0bn from $27.3bn (for reference, Omnitracs had $372 million in sales in FY13). Their FY14 EPS goes up to $5.51 from $5.28 to reflect the gain, which the company will include in non-GAAP EPS.

This will likely be only partially reflected in consensus, creating some confusion over the next quarter. Anaysts’ FY15/16 EPS estimates ticked down by $0.01 on the removal of Omnitracs. They see the sale as consistent with QUALCOMM, Inc. (NASDAQ:QCOM)’s increased focus on shareholder returns and cost controls. The $800 million boosts Qualcomm’s domestic cash balance to slightly under $9 billion. In addition, Qualcomm can more effectively focus on core R&D initiatives while reducing combined R&D and SG&A growth to 5-7% in FY14 vs. 23% growth in FY13.

Qualcomm’s valuation

There is no change to Goldman’s 12-month price target $82, based on 15X firm’s CY14 non-GAAP EPS of $5.44 (down from $5.45 due to Omnitracs).

Qualcomm’s key risks

Risks include lower device ASPs, royalty rate fluctuations, legal challenges, increasing competition, vertical integration, and customer concentration.

Updated on

Sheeraz is our COO (Chief - Operations), his primary duty is curating and editing of ValueWalk. He is main reason behind the rapid growth of the business. Sheeraz previously ran a taxation firm. He is an expert in technology, he has over 5.5 years of design, development and roll-out experience for SEO and SEM. - Email: sraza(at)www.valuewalk.com
Previous article Keeping Secrets: Pierre Omidyar, Glenn Greenwald and the privatization of Snowden’s leaks
Next article Galaxy S5: How Innovative Will Samsung Be This Time?

No posts to display